| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |